Every week on http://www.***.com/
Chaque semaine sur http://www.***.com/

Press review  (January 14, 2012) Revue de presse (14 janvier 2012)

Discovered: Mutation for Hereditary Prostate Cancer
Occurs in Less Than 2% of Affected Men.
By Nick Mulcahy. In Medscape
http://www.***.com/

Does Deodorant Ingredient Affect {*filter*} Cancer Risk?
Small study finds suspect chemical even in women who never used the
product, further muddying the debate.
By Kathleen Doheny. In U.S. News & World Report
http://www.***.com/

New Prostate Cancer Gene Mutation Discovered
After decades of work, researchers have discovered a new gene (HOXB13)
variant linked with a higher risk of developing hereditary prostate
cancer.
By Catherine Pearson. In Huffington Post
http://www.***.com/

U.S. Life Expectancy Rises as {*filter*}s Hit Lowest Since 1962
U.S. life expectancy climbed to a new high in 2010 as fewer people
died from heart disease and cancer, and {*filter*} was no longer among
the 15 leading causes of death, the Centers for Disease Control and
Prevention said.
By Molly Peterson. In Bloomberg
http://www.***.com/

Uncertainty Over Use of GnRH Agonists in {*filter*} Cancer
Infertility as a result of chemotherapy for {*filter*} cancer is not
improved with the use of a gonadotropin-releasing hormone (GnRH)
agonist (triptorelin), according to a new study.
By Zosia Chustecka. In Medscape Today
http://www.***.com/

Improvements in cancer research
Cancer Research UK Chief Executive Harpal Kumar sheds light on the
need for continued research to improve prevention, screening and
treatment.
In Public Service
http://www.***.com/

Lab-made tissue picks up the slack of Petri dishes in cancer research
New research demonstrates that previous models used to examine cancer
may not be complex enough to accurately mimic the true cancer
environment. Using {*filter*}cancer cells in a three-dimensional model of
lab-made tissue that mimics the lining of the {*filter*}cavity, the
researchers found that the tissue surrounding cancer cells can
epigenetically mediate, or temporarily trigger, the expression or
suppression of a cell adhesion protein associated with the progression
of cancer. These new findings support the notion that {*filter*} that are
currently being tested to treat many cancers need to be screened using
more complex tissue-like systems, rather than by using conventional
petri dish cultures that do not fully manifest features of many
cancers.
In ScienceCodex
http://www.***.com/

Sharing {*filter*} Cancer Results With Children Is Popular
An investigation published online in CANCER, a peer-reviewed journal
of the American Cancer Society has discovered that many parents share
their {*filter*} cancer test results with their children, even if they are
very young. Furthermore, the researchers discovered that the majority
of parents believe that their children are not distressed when they
find out about the test results.
By Grace Rattue. In Medical News Today
http://www.***.com/

ISG15: A novel therapeutic target to slow {*filter*} cancer cell motility
Interferon-stimulated gene 15 (ISG15), a ubiquitin like protein, is
highly elevated in a variety of cancers including {*filter*} cancer. How
the elevated ISG15 pathway contributes to tumorigenic phenotypes
remains unclear and is the subject of a study published in the January
2012 issue of Experimental Biology and Medicine.
In EurekAlert.
http://www.***.com/

Bach's charms soothe edgy prostate patients
A good set of headphones and a little Bach may ease the pain and
anxiety of getting a prostate biopsy, according to a newly published
study by Duke Cancer Institute researcher.
By Jay Price. In Vancouver Sun
http://www.***.com/ +charms+soothe+edgy+prostate+p...

Selectively stopping glutathione sensitizes brain tumors to
chemotherapy
Brain cancer cells are particularly resistant to chemotherapy toxins
enter the cells, but before the toxins can kill, cancer cells quickly
pump them back outside. In fact, brain cancer cells are even better
than healthy cells at cleaning themselves. This means that when hit
with chemotherapy, healthy cells tend to die before brain cancer
cells. Especially in the brain, killing healthy cells is bad.
In Medical Xpress
http://www.***.com/

Dcouverte du premier gne mutant cl dans le cancer hrit de la
prostate
Aprs vingt ans d'effort, des chercheurs amricains ont dcouvert la
premire mutation gntique majeure lie une nette augmentation du
risque de cancer hrditaire de la prostate, selon leurs travaux parus
mercredi dans le New England Journal of Medicine. Ce gne mutant rare
accro?t de dix vingt fois le risque de cancer de la prostate chez
les hommes les plus jeunes dans les familles affectes. Dans Le Monde
http://www.***.com/

Habiter prs d'une centrale nuclaire favoriserait la leucmie chez
l'enfant?
Selon une tude publie dans l'International Journal of Cancer, les
cas de leucmies seraient deux fois plus frquents chez les enfants
vivants proximit d'une centrale nuclaire. Les scientifiques
refusent cependant d'en tirer des conclusions dfinitives.
Par Denis Delbecq. Dans LExpress.
http://www.***.com/

14-3-3a: un gne qui freine le cancer du sein
Un travail publi en ligne dans Cancer Discovery fournit une nouvelle
preuve convaincante selon laquelle le gne 14-3-3a empche la
progression des tumeurs.
Dans Techno-Science.net
http://www.***.com/

Le nombre de cancers baisse aux Etats-Unis, un million de dcs vits
depuis 1990
Plus d'un million de dcs ont t vits aux Etats-Unis depuis le
dbut des annes 1990 grace la baisse du nombre de cancers, en
particulier du sein, du poumon, de la prostate et du colon, selon un
rapport publi mercredi par l'organisation amricaine contre le
cancer.
AFP
http://www.***.com/

Cancers et prothses mammaires: quand le doute ronge
Aucun lien de causalit na t dmontr, mais les autorits
sanitaires fran?aises sont profondment embarrasses.
Par Jean-Yves Nau. Dans Slate.fr
http://www.***.com/

Molcule innovante : Lon Brard part l'assaut de l'AKT
L'ARC et l'Inca financent un essai clinique valuant une nouvelle
thrapie cible dans le lymphome. Cet essai a t con?u et promu par
le Centre Lon Brard de Lyon. Fabien Calvo rpond Futurapolis.
Par Grard Desportes. Dans Le Point.fr
http://www.***.com/

Cancer Blog Marc Lacroix Le Blogue du Cancer
http://www.***.com/

Marc Lacroix InTextoResearch Baelen  (01/2012)